Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
headache; swell right breast; This non-serious case was reported by a consumer and described the occurrence of breast swelling in a 67-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 05-MAY-2025, the patient received Shingles vaccine. On 06-MAY-2025, 1 days after receiving Shingles vaccine, the patient experienced breast swelling (Verbatim: swell right breast). On an unknown date, the patient experienced headache (Verbatim: headache). The outcome of the breast swelling was not resolved and the outcome of the headache was resolved with sequelae. It was unknown if the reporter considered the breast swelling and headache to be related to Shingles vaccine. It was unknown if the company considered the breast swelling and headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 14-MAY-2025 The patient was a reporter. The patient experienced swell right breast and headache. Were the symptoms treated (swell right breast) was reported as no.